An in-depth pathway analysis within ST patients was performed, illustrating that patients with mixed histologic type presented lower PI3K pathway mutation levels than medullary carcinoma and apocrine carcinoma, but were still higher than NSTs. This evidence concerns the gene PIK3CA and apocrine adenocarcinoma.